Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC
Authors:
Open Access
- 1 January 2012
- journal article
- Published by The Korean Association of Immunobiologists in Immune Network
- Vol. 12 (6) , 269-276
Abstract
Baek S, et al. Immune Netw. 2012 Dec;12(6):269-276. https://doi.org/10.4110/in.2012.12.6.269Keywords
This publication has 23 references indexed in Scilit:
- Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trialJournal of Translational Medicine, 2011
- Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinomaClinical Immunology, 2007
- Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cellsLung Cancer, 2007
- Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord bloodVaccine, 2005
- Selective Generation of Different Dendritic Cell Precursors from CD34+Cells by Interleukin‐6 and Interleukin‐3Stem Cells, 2004
- Autologous Dendritic Cell Vaccines for Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic CellsJournal of Experimental Medicine, 2004
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.Journal of Experimental Medicine, 1996
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991